Browsing by Subject "Adjunct drugs"
Now showing items 1-1 of 1
-
Potential anti-TB investigational compounds and drugs with repurposing potential in TB therapy: a conspectus
(Springer, 2020)The latest WHO report estimates about 1.6 million global deaths annually from TB, which is further exacerbated by drug-resistant (DR) TB and comorbidities with diabetes and HIV. Exiguous dosing, incomplete treatment course, ...